Results 1 to 10 of about 5,147 (131)
Nephrogenic systemic fibrosis [PDF]
Clinical Case Reports, 2017 Key Clinical Message Nephrogenic systemic fibrosis (NSF) is a fibrosing disorder seen in patients with renal dysfunction, commonly precipitated by administration of gadolinium contrast.
Abhilash Koratala, Vikrampal Bhatti
doaj +4 more sources
Indian Dermatology Online Journal, 2011 Nephrogenic systemic fibrosis (NSF) is a relatively new fibrosing disorder which has caught the attention of various specialities in the past decade. NSF is an extremely disabling and often painful condition, affecting up to 13% of the individuals with ...
Bhushan Madke, Uday Khopkar
doaj +7 more sources
Understanding Nephrogenic Systemic Fibrosis [PDF]
International Journal of Nephrology, 2012 Nephrogenic systemic fibrosis (NSF) is a rare and a debilitating disease noted uncommonly in patients with impaired renal function when exposed to low-stability gadolinium-based contrast agents (Gd-CAs).
Tushar Chopra +4 more
doaj +5 more sources
Nephrogenic systemic fibrosis: A brief review
Indian Journal of Dermatology, 2011 Nephrogenic systemic fibrosis is a fibrosing disorder of the skin that develops in patients with advanced renal failure. It mostly presents with progressive hardening or induration of the skin of the extremities.
Rajesh Waikhom, Abhijit Taraphder
doaj +4 more sources
Nephrogenic systemic fibrosis: Current concepts
Indian Journal of Dermatology, 2011 Nephrogenic systemic fibrosis (NSF) was first described in 2000 as a scleromyxedema-like illness in patients on chronic hemodialysis. The relationship between NSF and gadolinium contrast during magnetic resonance imaging was postulated in 2006, and ...
Prasanta Basak, Stephen Jesmajian
doaj +4 more sources
Nephrogenic Systemic Fibrosis [PDF]
Magnetic Resonance Imaging Clinics of North America, 2009 There seems to be an association between exposure to intravenous gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF), a debilitating and sometimes fatal disease. This article addresses the relationship between GBCAs and NSF and answers some common questions.
Jeffrey Weinreb, Phillip H Kuo
exaly +19 more sources
Neutrophil elastase in the development of nephrogenic systemic fibrosis (NSF)-like skin lesion in renal failure mouse model. [PDF]
PLoS ONE, 2021 Although neutrophil elastase (NE) may play a role in lung fibrosis and liver fibrosis, NE involvement in the development of nephrogenic systemic fibrosis has been unclear.
A Adhipatria P Kartamihardja +7 more
doaj +3 more sources
Nephrogenic Systemic Fibrosis [PDF]
American Journal of Roentgenology, 2012 The purpose of this article is to discuss nephrogenic systemic fibrosis (NSF) in detail regarding its history, possible pathophysiology, clinical and pathologic presentations, diagnosis, and implications for the radiology community.NSF is a potentially lethal disorder that occurs in patients with reduced kidney function.
Rathachai Kaewlai, Hani Abujudeh
exaly +5 more sources
Nephrogenic systemic fibrosis. [PDF]
F1000 Med Rep, 2010 Nephrogenic systemic fibrosis, initially called nephrogenic fibrosing dermopathy, has been strongly linked to exposure to gadolinium-based contrast media used in magnetic resonance imaging in patients with renal insufficiency. This review discusses recent advances in our understanding of the pathophysiology and clinical approach to patients with ...
Braverman IM, Cowper S.
europepmc +9 more sources
Nephrogenic systemic fibrosis: Time for the requiem?
Indian Journal of Dermatology, 2011 Saumya Panda
doaj +4 more sources